Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,961,146
+$3,682,180 QoQ
Shares Held
74,659
+19.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
#759
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $65,318,341 across 13 Drug Manufacturers - General names. JNJ ranks #2 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,766 | $20,109,645 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
74,659 | $18,961,146 | |
| 3 | ABBV |
AbbVie Inc.
|
48,063 | $12,094,573 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,144 | $8,242,504 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,984 | $2,476,738 | |
| 6 | PFE |
Pfizer Inc
|
87,204 | $2,099,872 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,022 | $1,139,839 | |
| 8 | AZN |
Astrazeneca PLC
|
586 | $111,117 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,961,146 | 74,659 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,278,966 | 62,506 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,819,949 | 57,115 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,549,100 | 56,893 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,284,243 | 54,234 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,307,604 | 56,124 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,836,234 | 54,185 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,609,761 | 53,127 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,213,938 | 28,831 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $594,952 | 3,761 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $608,464 | 3,882 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $669,569 | 4,299 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $699,818 | 4,228 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $792,515 | 5,113 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,009,378 | 5,714 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,440,181 | 8,816 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,500,528 | 87,322 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,522,486 | 31,160 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,854,795 | 28,379 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,781,530 | 29,607 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,729,850 | 28,711 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,012,675 | 30,500 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,184,209 | 71,065 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,108,830 | 74,616 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,419,718 | 81,204 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,340,130 | 63,602 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||